Loading data...
Parsec Co., Ltd.
CEO
Shoji Maruyama
N/A
Recent News & PR
Summary
Message to Participants
Detailed Information
Parsec Co., Ltd. provides health management solutions that integrate AI and traditional medicine. Aiming for prevention at the pre-disease stage, we analyze tongue diagnosis and pulse diagnosis with AI to quantitatively understand individual health conditions and propose optimal improvement measures.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
SaaS / B2B Software, AI / Data Analytics, Healthcare / Biotech
本社所在地
Shibuya-ku, Tokyo, Japan
設立日
2022年4月21日
資本金
2990 万円
Employee Count
3
Industry Outlook & Trends for Parsec Co., Ltd.
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where Parsec Co., Ltd. operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by Parsec Co., Ltd..
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.